R Pu

956 total citations · 1 hit paper
8 papers, 846 citations indexed

About

R Pu is a scholar working on Virology, Epidemiology and Genetics. According to data from OpenAlex, R Pu has authored 8 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 5 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in R Pu's work include HIV Research and Treatment (5 papers), Virus-based gene therapy research (5 papers) and Herpesvirus Infections and Treatments (3 papers). R Pu is often cited by papers focused on HIV Research and Treatment (5 papers), Virus-based gene therapy research (5 papers) and Herpesvirus Infections and Treatments (3 papers). R Pu collaborates with scholars based in United States. R Pu's co-authors include M D Sadick, B J Holaday, Richard M. Locksley, Frederick P. Heinzel, Janet K. Yamamoto, Elizabeth W. Uhl, Tsutomu Hohdatsu, M B Gardner, Howard M. Johnson and Verónica Acevedo and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Virology and Transplantation.

In The Last Decade

R Pu

8 papers receiving 818 citations

Hit Papers

Cure of murine leishmaniasis with anti-interleukin 4 mono... 1990 2026 2002 2014 1990 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Pu United States 7 467 328 314 246 151 8 846
Diego A. Vargas‐Inchaustegui United States 16 232 0.5× 455 1.4× 277 0.9× 242 1.0× 65 0.4× 36 796
M J McElrath United States 12 375 0.8× 381 1.2× 319 1.0× 528 2.1× 48 0.3× 13 960
Joe Kansopon United States 14 765 1.6× 432 1.3× 220 0.7× 260 1.1× 77 0.5× 16 1.5k
Jean‐Hervé Colle France 17 227 0.5× 502 1.5× 151 0.5× 283 1.2× 53 0.4× 45 864
Nina Wedderburn United Kingdom 18 239 0.5× 365 1.1× 228 0.7× 77 0.3× 132 0.9× 55 931
Jay A. Berzofsky United States 9 295 0.6× 702 2.1× 75 0.2× 346 1.4× 63 0.4× 11 1.2k
F W Heessen Netherlands 16 523 1.1× 455 1.4× 76 0.2× 49 0.2× 98 0.6× 23 1.1k
Phil Felgner United States 9 311 0.7× 350 1.1× 141 0.4× 232 0.9× 59 0.4× 13 854
Adrian V. S. Hill United Kingdom 9 146 0.3× 380 1.2× 317 1.0× 135 0.5× 45 0.3× 11 701
Zohreh Sharifi Iran 15 410 0.9× 144 0.4× 185 0.6× 37 0.2× 39 0.3× 130 844

Countries citing papers authored by R Pu

Since Specialization
Citations

This map shows the geographic impact of R Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Pu more than expected).

Fields of papers citing papers by R Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Pu. The network helps show where R Pu may publish in the future.

Co-authorship network of co-authors of R Pu

This figure shows the co-authorship network connecting the top 25 collaborators of R Pu. A scholar is included among the top collaborators of R Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Pu. R Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sahay, Bikash, Meerambika Mishra, Andrew C. McAvoy, et al.. (2019). Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses. Viruses. 11(2). 136–136. 6 indexed citations
2.
Omori, Mayuko, R Pu, Taishi Tanabe, et al.. (2004). Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine. Vaccine. 23(3). 386–398. 27 indexed citations
3.
Uhl, Elizabeth W., et al.. (2002). FIV vaccine development and its importance to veterinary and human medicine: a review. Veterinary Immunology and Immunopathology. 90(3-4). 113–132. 93 indexed citations
4.
Gengozian, N., Leticia Reyes, R Pu, et al.. (1997). FRACTIONATION OF FELINE BONE MARROW WITH THE SOYBEAN AGGLUTININ LECTIN YIELDS POPULATIONS ENRICHED FOR ERYTHROID AND MYELOID ELEMENTS. Transplantation. 64(3). 510–518. 7 indexed citations
5.
Pu, R, Michael Tellier, & Janet K. Yamamoto. (1997). Mechanism(s) of FIV vaccine protection.. PubMed. 11 Suppl 3. 98–101. 10 indexed citations
6.
Yamamoto, Janet K., Tsutomu Hohdatsu, Robert A. Olmsted, et al.. (1993). Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. Journal of Virology. 67(1). 601–605. 89 indexed citations
7.
Hohdatsu, Tsutomu, et al.. (1993). Passive antibody protection of cats against feline immunodeficiency virus infection. Journal of Virology. 67(4). 2344–2348. 50 indexed citations
8.
Sadick, M D, et al.. (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.. The Journal of Experimental Medicine. 171(1). 115–127. 564 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026